Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for ...
Introduction Hepatocellular carcinoma (HCC) stands as the sixth most prevalent cancer and the fourth lethal malignancy across the globe.1 With its insidious onset and rapid progression, HCC often leads to a poor prognosis.2 Therefore, HCC with extrahepatic …